Literature DB >> 7646202

From aortic cusp extension to valve replacement with stentless pericardium.

C M Duran1, B Gometza, N Kumar, R Gallo, K Bjornstad.   

Abstract

Between 1988 and 1994, 82 consecutive patients (median age 24 years) underwent reconstruction of the aortic valve with glutaraldehyde-treated pericardium. Simultaneously, 29 of 30 mitral valves were repaired. The first 27 patients underwent resection of the free edges and suture of a single strip of bovine pericardium. Transient ischemic changes suggested the need for a change in technique. The subsequent 55 patients underwent total valve reconstruction with an autologous pericardium fixed with glutaraldehyde in the appropriate shape and size according to the patient's aortic annulus. There were one in-hospital and three late deaths. No patient received anticoagulation, and no embolic events were detected. Nine patients required reoperation as a result of failure of mitral valve repair in 4 and severe aortic regurgitation in 5 (endocarditis [n = 2], commissural tear [n = 1], root dilation [n = 1], calcification of one bovine cusp [n = 1] at 58 months). There were no reoperative deaths. Complete linear echocardiographic follow-up of these patients showed low gradients, valve competence, and no progressive deterioration. No difference between techniques was detected.

Entities:  

Mesh:

Year:  1995        PMID: 7646202     DOI: 10.1016/0003-4975(95)00200-5

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  6 in total

1.  Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Richard P Whitlock; Jack C Sun; Stephen E Fremes; Fraser D Rubens; Kevin H Teoh
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Aortic valve replacement with autologous pericardium: long-term follow-up of 15 patients and in vivo histopathological changes of autologous pericardium.

Authors:  Xiaohong Liu; Lin Han; Zhigang Song; Mengwei Tan; Dejun Gong; Zhiyun Xu
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-11-08

3.  Pulmonary valve leaflet extension with bovine pericardium: for treatment of pulmonary insufficiency.

Authors:  Tae Eun Jung; Jong Hyun Baek; Dong Hyup Lee
Journal:  Tex Heart Inst J       Date:  2011

4.  In vivo evaluation of an in-body, tissue-engineered, completely autologous valved conduit (biovalve type VI) as an aortic valve in a goat model.

Authors:  Yoshiaki Takewa; Masashi Yamanami; Yuichiro Kishimoto; Mamoru Arakawa; Keiichi Kanda; Yuichi Matsui; Tomonori Oie; Hatsue Ishibashi-Ueda; Tsutomu Tajikawa; Kenkichi Ohba; Hitoshi Yaku; Yoshiyuki Taenaka; Eisuke Tatsumi; Yasuhide Nakayama
Journal:  J Artif Organs       Date:  2012-12-20       Impact factor: 1.731

5.  Autologous pericardial aortic valve reconstruction: early results and comparison with mechanical valve replacement.

Authors:  Jeeva Vijayan; Rakesh Naik Lachma; Prasanna Simha Mohan Rao; Anand Subraya Bhat
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2019-09-10

6.  Short-term outcomes of aortic valve neocuspidization for various aortic valve diseases.

Authors:  Gregory Khatchatourov; Mathieu van Steenberghe; Doris Goy; Mathieu Potin; Javier Orrit; François Perret; Nicolas Murith; Jean-Jacques Goy
Journal:  JTCVS Open       Date:  2021-08-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.